39,635 views
http://www.medicinaeinformazione.com/ / medicinaeinformazione Reaching an early diagnosis in Parkinson's disease means being able to control the symptoms and slow down the disability due to tremors, movement or speech disorders... And today the possibilities of diagnosis also take into account non-motor symptoms that can appear even years before the most striking manifestation of the disease and can be taken into consideration for some tests such as dedicated CT or MRI that can also be combined with genetic tests that especially in juvenile forms can provide valuable indications. And also in the field of therapies, in addition to the now established therapy with levodopa, neuroprotective drugs are being developed that can slow the progression of the disease. We talk about all this with Dr. Antonio Elia, Specialist in Neurology of the Movement Disorders Unit of the Carlo Besta Neurological Institute in Milan who explained to us how it is essential to plan a personalized path for each patient that includes, in addition to the drugs, constant rehabilitation and monitoring over time with the use of movement analysis to be able to have a parametric feedback of the progress and response to the therapy. The role of antioxidants and indeed of the new neuroprotective drugs will be fundamental to contain the symptoms and already today it is possible to modulate various types of administration to optimize the response even in patients who have an incomplete benefit from the treatment - you can use levodopa infusions or transcranial stimulation in the most advanced cases of the disease - all this to offer the best possible quality of life without forgetting that often one of the manifestations of Parkinson's disease is depression which must be treated as such to prevent it from worsening the clinical picture and creating serious emotional distress for the patient and his family.